Tumor Treatment Field Therapy (TTFT) Contractor Advisory Committee (CAC) Agenda

The DME MACs are hosting a Contractor Advisory Committee (CAC) meeting to consider the scientific evidence for Tumor Treatment Field Therapy (TTFT).  The meeting will be held in the CMS auditorium on March 6, 2019 from 9 AM - 4 PM EST.  The agenda for the CAC meeting can be found here:

Tumor Treatment Field Therapy Contractor Advisory Committee

March 6, 2019 - CMS Auditorium

Agenda

Time Description
9:00 - 9:15 AM Introductions - DME MAC Medical Directors and CAC Panel - Dr. Hoover
9:15 - 9:30 AM Overview of Current TTFT LCD and Novocure Request - DME MAC Medical Directors
9:30 - 10:30 AM

Presentation of Technology and Evidence - Novocure

  • Matthew Ballo, MD, FACR
    Professor and Chairman, Department of Radiation Oncology, University of Tennessee Health Science Center
  • Adrian Kinzel MD, MHBA
    Vice President, Medical Affairs, Novocure
  • William Doyle
    Executive Chairman, Novocure
  • Optune® Patient
10:30 - 10:45 AM Break
10:45 - 12:30 PM Question & Answer for Novocure representative - CAC Panel
12:30 - 12:45 PM Review of Key Questions - CAC Chair
12:45 - 1:30 PM Lunch (On Your Own)
1:30 - 3:45 PM

Key Question Discussion & Summary of Conclusions - Chair/Panel

  • Leading of Discussion on Key Questions - Chair/Panel
3:45 - 4:00 PM Closing Comments - Dr. Hoover

 

Last Updated Wed, 19 Feb 2020 15:52:05 +0000